Silo Pharma, Inc. (SILO) — 8-K Filings

8-K Filings (22)

• Silo Pharma Faces Delisting Notice — Dec 29, 2025 Risk: high
  Silo Pharma, Inc. filed an 8-K on December 29, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, effective Decem
• Silo Pharma Files 8-K: Director Changes, Officer Appointments — Oct 24, 2025 Risk: medium
  On October 24, 2025, Silo Pharma, Inc. filed an 8-K report detailing several key events. The company announced the departure of a director, the election of a ne
• Silo Pharma, Inc. Files 8-K: Material Agreement, Equity Sales — Oct 1, 2025 Risk: medium
  On September 29, 2025, Silo Pharma, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and
• Silo Pharma Files 8-K — Aug 5, 2025 Risk: low
  Silo Pharma, Inc. filed an 8-K on August 5, 2025, reporting other events and financial statements. The company, formerly known as Uppercut Brands, Inc., Gold Sw
• Silo Pharma, Inc. Files 8-K: Material Agreement & Equity Sales — Jul 29, 2025 Risk: medium
  On July 29, 2025, Silo Pharma, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other
• Silo Pharma Enters Material Definitive Agreement — Jul 10, 2025 Risk: medium
  On July 8, 2025, Silo Pharma, Inc. entered into a material definitive agreement. The company, formerly known as Uppercut Brands, Inc., Point Capital, Inc., and
• Silo Pharma Faces Delisting Concerns — Jul 3, 2025 Risk: high
  Silo Pharma, Inc. filed an 8-K on July 3, 2025, reporting a notice of delisting or failure to satisfy continued listing rules as of June 27, 2025. The company,
• Silo Pharma Enters Material Definitive Agreement — May 16, 2025 Risk: medium
  On May 15, 2025, Silo Pharma, Inc. entered into a material definitive agreement. The company, formerly known as Uppercut Brands, Inc., Point Capital, Inc., and
• Silo Pharma Files 8-K: Regulation FD Disclosure & Other Events — Mar 10, 2025 Risk: low
  On March 10, 2025, Silo Pharma, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The company, formerly known as Uppercut Brands,
• Silo Pharma Files 8-K — Mar 7, 2025 Risk: low
  Silo Pharma, Inc. filed an 8-K on March 7, 2025, reporting other events and financial statements as of March 4, 2025. The company, formerly known as Uppercut Br
• Silo Pharma Files 8-K Report — Jan 2, 2025 Risk: low
  On January 2, 2025, Silo Pharma, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The company, fo
• Silo Pharma Files 8-K on Shareholder Votes — Dec 20, 2024 Risk: low
  Silo Pharma, Inc. filed an 8-K on December 20, 2024, to report on matters submitted to a vote of its security holders. The filing does not contain specific deta
• Silo Pharma Files 8-K — Nov 8, 2024 Risk: low
  On November 8, 2024, Silo Pharma, Inc. filed an 8-K report detailing an "Other Event." The filing does not contain specific financial figures or new material ag
• Silo Pharma, Inc. Files 8-K with Updates — Sep 10, 2024 Risk: low
  On September 10, 2024, Silo Pharma, Inc. filed an 8-K report detailing a Regulation FD Disclosure and Other Events. The filing also includes financial statement
• Silo Pharma, Inc. Files 8-K for Material Agreement — Jul 22, 2024 Risk: medium
  On July 18, 2024, Silo Pharma, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also
• Silo Pharma, Inc. Files 8-K with Material Agreement — Jul 8, 2024 Risk: medium
  On July 1, 2024, Silo Pharma, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also r
• Silo Pharma Enters Material Definitive Agreement — Jun 27, 2024 Risk: medium
  Silo Pharma, Inc. announced on June 26, 2024, that it entered into a material definitive agreement. The company, formerly known as Uppercut Brands, Inc., Point
• Silo Pharma, Inc. Files 8-K for Material Agreement — Jun 6, 2024 Risk: medium
  On June 4, 2024, Silo Pharma, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities and other
• Silo Pharma Files 8-K — Jun 4, 2024 Risk: low
  Silo Pharma, Inc. filed an 8-K on June 4, 2024, reporting other events and financial statements. The company, formerly known as Uppercut Brands, Inc., Point Cap
• Silo Pharma Files 8-K: Other Events & Exhibits — Apr 5, 2024 Risk: low
  On April 4, 2024, Silo Pharma, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits." The company, form
• Silo Pharma Files Routine 8-K for 'Other Event' on Feb 1, 2024 — Feb 1, 2024
  Silo Pharma, Inc. filed an 8-K on February 1, 2024, to report an "Other Event" and provide updated financial statements and exhibits. This filing primarily serv
• Silo Pharma Updates Business Address to Sarasota, FL — Jan 9, 2024
  Silo Pharma, Inc. filed an 8-K on January 9, 2024, to update its business address from 560 Sylvan Ave, Suite 3160, Englewood Cliffs, NJ 07632 to 677 N. Washingt

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX